Hutch Expert Directory

Dr. Larry Corey has led some of the most significant advances in medicine in the last 30 years, including the development of safe and effective antivirals for herpes viruses, HIV and hepatitis infections. Dr. Corey is co-prinicpal investigator of the HIV Vaccine Trials Network. Read more

Matthew Trunnell, Fred Hutchinson Cancer Research Center’s chief information officer, responsible for many key areas at Fred Hutch, including research informatics and enterprise information technology.
Read more

Dr. Colleen Delaney, Director for the Fred Hutch Cord Blood Program, developed a method for multiplying, or expanding, key stem cells in cord blood, with the goal of extending the use of this expanded cord blood product into something that could be ordered up by doctors at a moment’s notice.  Her vision is to create a therapy that can become FDA approved and be given to patients around the world.
Read more

Dr. Denise Galloway studies the mechanisms by which human papillomaviruses contribute to cancer, with an emphasis on types most likely to progress to cervical cancer. Her research has led to breakthrough contributions to a vaccine that prevents HPV and averts tens of thousands of cervical cancer cases each year.
Read more

Dr. Philip Greenberg is head of the Program in Immunology.  His laboratory performed some of the earliest studies focused on how immune T cells can recognize and eliminate malignant cells in the context of progressing tumors and has developed technologies to isolate and expand functional, target (antigen)-specific T cells to numbers large enough to be effective when given to patients as adoptive immune-boosting therapy.
Read more

Dr. Stanley Riddell led the first human trial of adoptively transferred T cell clones to prevent cytomegalovirus infection after allogeneic hematopeietic transplantation. His research team has developed new techniques for isolation, expansion, genetic modification and reinfusion of T cells, and for monitoring safety, persistence, migration and function after transfer. Many of these innovative methods are now widely used.
Read more

Dr. Gary Gilliland is president and director of Seattle’s Fred Hutchinson Cancer Research Center. He is an expert in cancer genetics and precision medicine who has devoted his life to finding better treatments and cures for diseases.
Read more

Christine Gregoire is well-known throughout Washington state for her career in public service. An advocate for education, jobs and reform, through her role in the state attorney general’s office and governor’s office, Gregoire has a deep passion for the state of Washington and securing its future.
Read more

Dr. Amanda Paulovich is focused on the development of technologies and strategies for translation of novel diagnostics, and relieving a prohibitive roadblock in biomedical research: a lack of validated and standardized tools for quantifying proteins.
Read more

Dr. Eric Holland is an internationally renowned neurosurgeon and brain cancer researcher, and Senior Vice President at Fred Hutch and Director of the Human Biology Division. He is also Director of the Seattle Translational Tumor Research program —a new multi-institutional initiative targeting solid tumors and spanning all divisions and disciplines. 
Read more